Stephanie Hedt, MPP

Director of Communications, USC Schaeffer Center

Stephanie Hedt, MPP's contact information

Stephanie Hedt, MPP's Bio

Stephanie Hedt is the Director of Communications for the USC Schaeffer Center. A member of the external affairs team, she develops and oversees the communications strategy for the Center.

Stephanie has over 10 years of experience working in nonprofit administration and communication. Her experience includes personnel and organizational administration for Head Start, Early Head Start and California State Preschool programs; managing AmeriCorps members for a California Conservation Corps program; and building a food security program for the International Rescue Committee. While working toward her master's, she helped conduct research on public health interventions in South Los Angeles as part of a research project for the Centers for Disease Control and Prevention.

She holds a bachelor's in both communication and anthropology from the University of Washington,  and a master's of public policy from the USC Price School of Public Policy.

Recent Work

  • Schaeffer Center Research Programs

    Schaeffer Center Research Programs For more than 10 years, Schaeffer Center experts have worked to advance innovative prescription drug payment models that lead to better health and long-term returns. We have shed light on the broken—and at times distorted—pharmaceutical distribution system and provided policy solutions that benefit patients. We have advanced solutions to improve healthcare […]

    Categorized in
  • Developing Effective Payment and Reimbursement Models

    Targeted therapies can come with significant costs. But successful use of personalized medicine can also result in better healthcare outcomes and reduced long-term costs over time. Given this, how we pay for these therapies may require new approaches and models.

    Categorized in
  • Measuring Real-World Effectiveness and Value

    Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints.  Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial.

    Categorized in
  • Leveraging Precision Medicine to Meet Patient Needs

    Precision medicine promises to reduce adverse side effects and time-consuming trial and error processes, but many patients do not know what it is and providers struggle to leverage it effectively.

    Categorized in
  • Can Health Technology Assessment Control Spending and Reward Innovation?

    Could an Institute of Health Technology Assessment facilitate more rational decisions on healthcare that reward both innovation and quality across the entire spectrum of care?

    Categorized in
Load More